APA

Lievano G., Di Domenico D., Brown J., Bridges P., Rubenstein M., Shaw M. & Guinan P. (19970902). Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma. : Methods and findings in experimental and clinical pharmacology.

Chicago

Lievano G, Di Domenico D, Brown J, Bridges P, Rubenstein M, Shaw M and Guinan P. 19970902. Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma. : Methods and findings in experimental and clinical pharmacology.

Harvard

Lievano G., Di Domenico D., Brown J., Bridges P., Rubenstein M., Shaw M. and Guinan P. (19970902). Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma. : Methods and findings in experimental and clinical pharmacology.

MLA

Lievano G, Di Domenico D, Brown J, Bridges P, Rubenstein M, Shaw M and Guinan P. Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma. : Methods and findings in experimental and clinical pharmacology. 19970902.